BOSTON, Massachusetts, Feb. 5 (TNSjou) -- Beth Israel Deaconess Medical Center issued the following news:

* * *

Semaglutide Improves Cardiovascular Health but Price Reductions Are Needed To Make It Cost-Effective, Study Finds

Study Coincides With Ongoing Negotiations To Bring Down Semaglutide Prices

*

Semaglutide, the active ingredient in the weight-loss medications Ozempic and Wegovy, offers substantial cardiovascular benefits for . . .

Click here for more information about our products